Sponsored Content
Modular Approaches in ATMP Innovation
The Biopharmaceutical facility design is changing as new modalities are developed and discovered. The Biopharma industry is heading into an individual targeted medicine era which requires flexible facility solutions.
Traditional facility designs limited their ability to react to the changes required of these new modalities as they often had the following characteristics:
- Generally, purpose built
- Bespoke designs
- Process that was coupled to the facility
- Often to produce large volumes
- Often Single product
- Stick built
- Often inflexible, difficult to modify and expand or to re-purpose
